Evidence mapPaperPMID 38641658Full record

ReviewNature reviews. Nephrology2024

Calcium signalling and transport in the kidney.

Alexander Staruschenko, R Todd Alexander, Michael J Caplan, Daria V Ilatovskaya

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 23 citations in OpenAlex.

  1. Proteomic Analysis of Dairy Cows with Persistent Subclinical Hypocalcemia.Animals : an open access journal from MDPI · 2026
    Article
  2. Engineered Au@CeOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Oxidative Stress in Heat Stress Nephropathy: Crosstalk.Oxidative medicine and cellular longevity · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. The effects of Cannabidiol on podocytes in vitro.Biochemical and biophysical research communications · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. PIEZO1-Mediated Calcium Signaling and Podocyte Injury in Diabetic Kidney Disease.Journal of the American Society of Nephrology : JASN · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Alexander StaruschenkoDepartment of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. staruschenko@usf.edu.ORCID 0000-0002-5190-8356
R Todd AlexanderDepartment of Paediatrics, University of Alberta, Edmonton, AB, Canada.
Michael J CaplanDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.
Daria V IlatovskayaDepartment of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Augusta University · USUniversity of Alberta · CAUniversity of South Florida · USYale University · US

Funding

The Impact of Obesity and Leptin on the Development of Immune System Dysfunction and Hypertension in Females with Systemic Lupus ErythematousU54HL169191 · AUGUSTA UNIVERSITY · 2025 to 2025
$1.5M
Sexual dimorphisms and role of the cGAS-STING pathway in diabetic nephropathyR01DK135644 · UNIVERSITY OF SOUTH FLORIDA · 2025 to 2025
$513k
Renal diabetic complications mediated by the PAR1 signaling in podocytesR01DK129227 · UNIVERSITY OF SOUTH FLORIDA · 2025 to 2025
$326k
Transport and metabolism in the kidneyI01BX004024 · VA · JAMES A. HALEY VA MEDICAL CENTER · 2021 to 2025
American Heart Association-American Stroke Association 953730BLRD VA I01 BX004024Department of Defense PR191158NHLBI NIH HHS R01 HL148114NHLBI NIH HHS R35 HL135749NIDDK NIH HHS R01 DK129227NIDDK NIH HHS R01 DK135644NIDDK NIH HHS RC2 DK120534NIDDK NIH HHS RC2 DK120534-01
6 · The paper itself

Abstract

The kidney plays a pivotal role in regulating calcium levels within the body. Approximately 98% of the filtered calcium is reabsorbed in the nephron, and this process is tightly controlled to maintain calcium homeostasis, which is required to facilitate optimal bone mineralization, preserve serum calcium levels within a narrow range, and support intracellular signalling mechanisms. The maintenance of these functions is attributed to a delicate balance achieved by various calcium channels, transporters, and calcium-binding proteins in renal cells. Perturbation of this balance due to deficiency or dysfunction of calcium channels and calcium-binding proteins can lead to severe complications. For example, polycystic kidney disease is linked to aberrant calcium transport and signalling. Furthermore, dysregulation of calcium levels can promote the formation of kidney stones. This Review provides an updated description of the key aspects of calcium handling in the kidney, focusing on the function of various calcium channels and the physiological stimuli that control these channels or are communicated through them. A discussion of the role of calcium as an intracellular second messenger and the pathophysiology of renal calcium dysregulation, as well as a summary of gaps in knowledge and future prospects, are also included.

Indexed as

CalciumCalcium ChannelsCalcium SignalingKidneyAnimalsHomeostasisHumansCalciumCalcium Channels

Identifiers

PMID38641658
PMCPMC12036682
OpenAlexW4394951976

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.